NEW YORK ( TheStreet) -- J&J's ( JNJ) most recent Tylenol and over-the-counter drug recall has been one of the hottest topics on the Internet after the company said that 2.5 million bottles could be affected by it.

Johnson & Johnson has been expanding its recall of OTC medicines including Tylenol, Motrin and Benadryl on Thursday and June 15 mainly due to a "musty or moldy odor."
Tylenol Recall

"We shipped approximately 2.5 million bottles of the affected lots involved in yesterday's recall," said a company spokeswoman after widespread complaints about the company's lack of transparency about the latest recall, Reuters reported on Friday.

Thursday's recall includes certain versions of Children's Tylenol, adult-strength Benadryl, Motrin IB, Tylenol Extra Strength, Tylenol Day & Night and Tylenol PM. The affected medicines were sold in America, Puerto Rico, Fiji, Guatemala, the Dominican Republic, Trinidad and Tobago, and Jamaica.

This is the fifth recall in nine months for J&J's McNeil Consumer Healthcare division, which had earlier declined to quantify the bottles of medicine included in the new recall. To date, the company has recalled at least 53 million bottles of popular over the counter medicine due to strange odors.

J&J stock has edged 0.1% lower to $60.487 one hour into Monday's regular trading session, in contrast with the broader equities which has been edging higher.
McNeil Recall Information
McNeil Product Recall Details

-- Reported by Andrea Tse in New York

RELATED STORIES:

Get more stock ideas and investing advice on our sister site, Stockpickr.com.

Follow Andrea Tse on Twitter and become a fan on Facebook.
Copyright 2010 TheStreet.com Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

If you liked this article you might like

Dow Trades Lower as Walmart Shares Fall Sharply, S&P 500 Wavers

Dow Trades Lower as Walmart Shares Fall Sharply, S&P 500 Wavers

Buy Stocks That Are Right for You: Cramer's 'Mad Money' Recap (Friday 2/16/18)

Buy Stocks That Are Right for You: Cramer's 'Mad Money' Recap (Friday 2/16/18)

Jim Cramer: These 4 Stocks Seem Attractive Right Here

Jim Cramer: These 4 Stocks Seem Attractive Right Here

Jim Cramer: Drug Stocks on the Move

Jim Cramer: Drug Stocks on the Move

The Decline In Johnson & Johnson Could Be Close to Being Over

The Decline In Johnson & Johnson Could Be Close to Being Over